URO-1 Medical

URO‑1 Medical has developed proprietary prostate biopsy instruments (SUREcore® Biopsy Needle and coreCARE® Specimen Retrieval) designed to improve the quality and quantity of tissue samples for more accurate diagnosis and genomic profiling. The company plans a commercial launch in 2024 following successful product development milestones. No clinical trial results are published; focus has been on device engineering, regulatory preparation, and market entry. Early feedback highlights improved sample integrity and reduced diagnostic delays compared to standard-of-care needle biopsies. The company’s products aim to become the new standard of care for prostate and other soft tissue biopsies.